FindTrial
Sign In

Strain for Risk Assessment and Therapeutic Strategies in Patients With Hypertensive Heart Disease (STRATS-HHD) Registry

Prognostic Implication of Left Ventricular Hypertrophy Regression After Antihypertensive Therapy in Patients with Hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008091
Enrollment
2100
Registered
2023-01-09
Start date
2022-07-01
Completion date
Unknown
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with hypertension at Seoul National University or Chung-Ang University Hospital, and underwent echocardiography within 1 month of the diagnosis

Exclusion criteria

Exclusion criteria: (1) specific cardiomyopathy, such as dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, ischemic cardiomyopathy, stress-induced cardiomyopathy, Fabry disease, and MELAS syndrome, etc. (2) end-stage renal disease (3) prior open heart surgery

Design outcomes

Primary

MeasureTime frame
Composite of cardiovascular death, cardiovascular events, and hospitalization for heart failure—

Secondary

MeasureTime frame
Cardiovascular death;All-cause death;Hospitalization for heart failure;Cardiovascular events: coronary revascularization, stroke, aortic events—

Countries

Korea, Republic of

Contacts

Public ContactIn-Chang Hwang

Seoul National University Bundang Hospital

inchang.hwang@gmail.com+82-31-787-7065

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026